Chemical Structure : MMI-0100
Catalog No.: PC-38783Not For Human Use, Lab Use Only.
MMI-0100 is a cell-permeant peptide inhibitor of MAPKAP kinase 2 (MK2), inhibits MK2 and downstream fibrosis and inflammation.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MMI-0100 is a cell-permeant peptide inhibitor of MAPKAP kinase 2 (MK2), inhibits MK2 and downstream fibrosis and inflammation.
MMI-0100 prevents vein graft intimal thickening ex vivo and in vivo.
MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.
MMI-0100 treatment reduced cardiac fibrosis, decreased cardiac hypertrophy, and prolonged survival in fibrotic cMyBPC40k disease mice model.
M.Wt | 2283.67 | |
Formula | ||
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Akihito Muto, et al. Vascul Pharmacol. Jan-Feb 2012;56(1-2):47-55.
2. Meng Q, et al. J Am Heart Assoc. 2017 Sep 4;6(9):e006590.
3. Xu L, et al. J Mol Cell Cardiol. 2014 Dec;77:86-101.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright